Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Hyogo College of Medicine, Hyogo, Japan.
Inflamm Bowel Dis. 2021 Oct 20;27(11):1747-1755. doi: 10.1093/ibd/izab016.
The Ulcerative Colitis (UC) Narrative is a global patient and physician survey aimed at identifying the impact of UC and comparing and contrasting perceptions of UC burden and management approaches.
Surveys of patients with UC (self-reported diagnosis; n = 2100) and physicians (n = 1254) were completed across 10 countries by The Harris Poll between August 2017 and February 2018. Questionnaires covered multiple aspects of UC, including diagnosis, treatment, and impact on patient quality of life, in addition to standard demographic information. Descriptive statistics are reported.
The majority of patients (82%) had moderate to severe UC (based on medication history; those who had only ever taken 5-aminosalicylates were excluded); 67% described their UC as controlled with few to no symptoms. On average, patients experienced 4.3 flares (standard deviation, 7.4) in the past year. Diagnostic delay was on average 2.0 years (standard deviation, 5.4); 42% of patients waited ≥1 year. Most patients (65%) felt that UC controlled their life rather than them controlling their disease. Because of the fear of repercussions, many patients had not disclosed their UC to their employer. Discussion of the emotional impact of UC during routine appointments was less of a priority for physicians, compared with patients.
The data from this global survey highlight that patients with UC experience diagnostic delay, poor disease control, and adverse impact on their quality of life. Patients report UC to be a mentally exhausting condition; however, emotional and mental health issues are infrequently discussed at routine appointments.
溃疡性结肠炎(UC)叙事是一项全球性的患者和医生调查,旨在确定 UC 的影响,并比较和对比 UC 负担和管理方法的认知。
2017 年 8 月至 2018 年 2 月期间,The Harris Poll 在 10 个国家/地区对溃疡性结肠炎患者(自我报告诊断;n=2100)和医生(n=1254)进行了调查。调查问卷涵盖了 UC 的多个方面,包括诊断、治疗以及对患者生活质量的影响,此外还包括标准的人口统计学信息。报告了描述性统计数据。
大多数患者(82%)患有中重度 UC(基于用药史;排除仅服用过 5-氨基水杨酸的患者);67%的患者自述 UC 得到控制,症状很少或没有。平均而言,患者在过去一年中经历了 4.3 次发作(标准差,7.4)。平均诊断延迟 2.0 年(标准差,5.4);42%的患者等待了≥1 年。大多数患者(65%)认为 UC 控制了他们的生活,而不是他们控制了疾病。由于担心后果,许多患者没有向雇主透露他们的 UC。与患者相比,医生在常规就诊时较少讨论 UC 的情绪影响。
这项全球调查的数据突显了 UC 患者存在诊断延迟、疾病控制不佳和生活质量受到不良影响的问题。患者报告 UC 是一种精神疲惫的疾病;然而,情绪和心理健康问题在常规就诊时很少被讨论。